About this Event
Performance starts with the brain. Unlock the secrets to peak cognitive performance in our upcoming FREE webinar.
Join us for an enlightening panel discussion featuring esteemed leaders and pioneers in cognitive innovation. Delve into the latest research and strategies for optimizing brain health, enhancing memory, and boosting cognitive function. Whether you're a professional seeking to sharpen your mental acuity or simply curious about unlocking your brain's full potential, this webinar is your gateway to actionable insights and expert advice.
Don't miss this opportunity to empower yourself with the knowledge to thrive mentally in an increasingly demanding world. As the world evolves, we must adapt our thinking and embrace new approaches to protect and enhance our most important asset: our brains.
Register now and embark on the journey to unlock your cognitive potential!
- Dr. Ryan C.N. D'Arcy: President and Chief Scientific Officer, NeuroCatch Inc.
- Oliver Moorhouse: Founder and SVP Business Development, BrainLit
- Brian McMahon: Chief Strategy Officer, deltaG
- Satoshi Takano: Founder & Lead Cognition Developer, ReactForge Inc.
- Liam Pingree: Co-Founder, Neuronic
- Understand the fundamentals of brain health and its impact on cognitive performance
- Explore the latest scientific research and innovations in cognitive enhancement
- Engage with leading experts in the field of cognitive innovation through interactive discussions and Q&A sessions
- Learn about new technologies in the brain health space and how these technologies can be utilized in your clinic or training center
NeuroCatch Inc. is a medical device company focused on improving brain health. Based on science and research, the company is focused on translating neuroscience research innovations into real-world medical devices. The flagship product, the NeuroCatch® Platform, is an industry-leading medical device that offers an objective evaluation of cognitive function, which is delivered in minutes at the point of care. The NeuroCatch Platform can provide value at any time in the care continuum, from initial evaluation or post-injury through ongoing treatment, with immediate results to help guide clinical decisions and evaluate effectiveness of interventions.
About BrainLit:
BrainLit is a health-tech company that focuses on light system solutions to improve well-being, health and performance. The company was founded in Lund in 2012 by Tord Wingren, one of the inventors of Bluetooth technology. Together with a dedicated team, BioCentric Lighting™ (BCL), developed a lighting system focusing on human health and well-being. BioCentric Lighting™ mimics natural daylight indoors, which forms the basis of BrainLit’s product families.
About deltaG®:
Developed through a collaboration between the University of Oxford and the NIH with funding from DARPA’s “Metabolic Dominance” program, deltaG allows users to attain deep states of ketosis without the need for dietary interventions. With over 55 published studies, the ketone monoester technology helps users utilize the power of ketones, not only as an energy source but also as a signaling molecule within the body. Users can now enhance both physical and cognitive performance while actively combating the primary instigators of metabolic dysfunction.
About ReactForge:
As a sports performance and technology company, ReactForge provides cognitive development to athletes, sports teams and other market verticals that include corporate, academic and lifestyle wellness. A proprietary training system called ReactOS helps individuals of all ages tap into their peak performance potential for all types of activities and sports.
About Neuronic:
Neuronic was founded with a singular focus: to keep the brain capacity in all stages of life high. They have set themselves the goal to maintain and enhance the most important organ - the brain. They have created the Neuradiant 1070, a groundbreaking self-administered light therapy device featuring 1070nm brain stimulation to enhance cognitive and behavioral functioning. Neuronic devotes 100% of profits to advance the science and development of photobiomodulation, through an ongoing program of basic science and applied clinical trials.
Event Venue
Online
CAD 0.00